Erlotinib in Women With Previously Untreated Adenocarcinoma of the Lung

Clinical trial NCT00137839 · COMPLETED

Trial details

NCT number: NCT00137839
Sponsor: Pasi A. Janne, MD, PhD
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma Non-small Cell Lung Cancer

Start date: 2004-11-01
Primary completion: 2008-11-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.